The study, published in the medical journal Cureus on 08 Apr 2024, examined age-adjusted mortality rates for 20 different types of cancer in Japan using official statistics on death, SARS-CoV-2 infections, and vaccination rates from 2020 to 2022. Japan has some of the highest vaccination rates globally and is now administering its seventh vaccine dose.

According to the study, there were no excessive cancer mortality (-0.4 per cent) during the initial year of the pandemic in 2020. However, a notable surge in cancer mortality coincided with the onset of mass vaccination campaigns in subsequent years.

The study found some excess cancer mortality of 1.1 per cent after the mass vaccination campaigns with the first and second doses in 2021 and then higher excess cancer mortality of 2.1 per cent in 2022 after the roll-out of the third vaccine dose. In 2022, excess mortality for all cancers, specifically oestrogen and oestrogen receptor alpha (ER?)-sensitive cancers, including ovarian, leukaemia, prostrate, lip/oral/pharyngeal, pancreatic and breast cancers, become substantial.

Breast cancer, which exhibited a notable deficit in mortality rates in 2020, transitioned to excess mortality in 2022 after the third vaccine dose, but certain cancers, like pancreatic cancer, displayed a steady rise predating the pandemic. Then, all six cancer types exceeded anticipated mortality values and rates in 2021 and 2022.

The researchers argued that even with reduced cancer screenings and limited healthcare access at that time, the mortality rate increase in these cancer types is still unexplained due to resolved restrictions on healthcare access for cancer screenings and treatments in 2022.

Aside from the ER?-sensitive cancers, the study further underscores a concerning trend in mortality rates for the most fatal cancers – lung, colorectal, stomach and liver cancers – which were declining before the pandemic. Nevertheless, the rate of decline decelerated following the COVID-19 vaccine roll-out.

The highest number of cancer-related mortality occurred among individuals aged 80 to 84, with over 90 per cent of this group having received a third vaccine dose. Almost 100 per cent of the vaccines administered were mRNA-based, predominantly Pfizer’s (78 per cent), followed by Moderna’s (22 per cent).

Furthermore, the researchers noted that reduced cancer screenings and limited healthcare access during lockdowns could partially account for cancer mortality.

The study's findings add to a growing body of evidence suggesting significant risks associated with COVID-19 vaccines, which were fast-tracked under the Operation Warp Speed initiative during the Trump administration.

According to data from the federal Vaccine Adverse Event Reporting System (VAERS), as of March 29, there have been 37,382 reported deaths, 215,734 hospitalisations, 21,616 heart attacks and 28,299 cases of myocarditis and pericarditis following COVID-19 vaccination. The Centers for Disease Control and Prevention (CDC) researchers have acknowledged a significant under-reporting of adverse events to VAERS, particularly regarding cases of myocarditis.

Investigative journalism organisation Project Veritas has shed light on the issue of under-reporting through undercover footage from inside the Phoenix Indian Medical Centre. In the footage, healthcare professionals express concerns about the lack of reporting of myocarditis cases, attributing it to bureaucratic hurdles and a desire to downplay adverse effects.

A comprehensive analysis published in the journal Vaccine, encompassing 99 million individuals across eight countries, revealed significantly higher risks of myocarditis following mRNA-based COVID-19 vaccines. The study also revealed potential associations with other serious conditions such as pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis.

In a recent development, the CDC was compelled by a court order to disclose 780,000 previously undisclosed reports of severe adverse reactions.

Meanwhile, in Florida, USA, a grand jury convened by Republican Gov. Ron DeSantis is investigating the production and distribution of COVID-19 vaccines. In Feb, the grand jury released an interim report challenging the efficacy of lockdowns, mask mandates and the severity of COVID-19 for specific demographics.

26/04/2024

Source